Brian Slomovitz and David M. Gershenson/LinkedIn
May 14, 2026, 17:13
Ribociclib Plus Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary – IJGC
International Journal of Gynecological Cancer (IJGC), shared a post on LinkedIn:
”New IJGC Conversations episode!
Ribociclib+Letrozole in Recurrent Low-Grade Serous Carcinoma of the Ovary: GOG3026 with Brian Slomovitz and David Gershenson
Tune in now.”
Proceed to the video attached to the post.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic